stockrowStryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −12.4%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
Follow SYK
Alert me
Stryker Corporation (SYK) Revenue growth
Stryker Corporation's revenue growth over the twelve months to 30 September 2026 was 7.87%, down 3.3 percentage points from fiscal 2025 (11.2%). Over the past ten years it has ranged from −3.58% (fiscal 2020) to 19.2% (fiscal 2021); the current reading is higher than 82% of that period. That is below the Medical Devices industry median of 10.4% and in line with the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 11.2% | 0.93 |
| FY2024 | 10.2% | (0.88) |
| FY2023 | 11.1% | 3.27 |
| FY2022 | 7.84% | (11.37) |
| FY2021 | 19.2% | 22.79 |
| FY2020 | −3.58% | (13.01) |
| FY2019 | 9.43% | 0.13 |
| FY2018 | 9.30% | (0.58) |
| FY2017 | 9.88% | (3.98) |
| FY2016 | 13.9% | 11.06 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 7.64% | (1.78) |
| Jun 2026 | 9.42% | 6.79 |
| Mar 2026 | 2.63% | (8.79) |
| Dec 2025 | 11.4% | 1.17 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| EW Edwards Lifesciences Corporation compare | 13.4% |
| DXCM DexCom, Inc. compare | 13.0% |
| ABT Abbott Laboratories compare | 10.0% |
| MDT Medtronic PLC compare | 9.77% |
| BSX Boston Scientific Corporation compare | 8.87% |
| STE STERIS plc compare | 8.12% |
| PHG Koninklijke Philips N.V. compare | 7.98% |
| SYK Stryker Corporation | 7.87% |
| GEHC GE HealthCare Technologies Inc. compare | 6.87% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement